Medidata
Medidata Solutions, Inc., headquartered in the United States, is a leading player in the life sciences industry, specialising in cloud-based solutions for clinical trials. Founded in 1999, the company has achieved significant milestones, including the development of innovative technologies that streamline the drug development process. With a strong presence in North America, Europe, and Asia, Medidata offers a comprehensive suite of products and services, including data management, analytics, and patient engagement tools. Their unique platform integrates advanced analytics and artificial intelligence, enabling biopharmaceutical companies to enhance decision-making and improve trial outcomes. Recognised for its market leadership, Medidata has been instrumental in transforming clinical research, supporting over 25,000 trials and 5 million patients globally. The company’s commitment to innovation and excellence positions it as a trusted partner in the evolving landscape of clinical development.
DitchCarbon Score
How does Medidata's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medidata's score of 50 is higher than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Medidata's reported carbon emissions
In 2019, Medidata Solutions, Inc. reported total carbon emissions of approximately 15,000,000 kg CO2e from Scope 3, which includes significant contributions from business travel (about 15,014,000 kg CO2e) and employee commuting (approximately 9,747,000 kg CO2e). The company also recorded Scope 1 emissions of about 242,160 kg CO2e and Scope 2 emissions of approximately 1,834,440 kg CO2e. Medidata is committed to reducing its carbon footprint, with initiatives aimed at achieving a fossil fuel-free fleet of company cars by 2025. This initiative targets reductions in both Scope 1 and Scope 2 emissions, contributing to their overall climate strategy. The emissions data is cascaded from Medidata Solutions, Inc., which is a current subsidiary of Dassault Systèmes SE. This relationship influences their sustainability targets and reporting practices. Medidata's climate commitments align with industry standards, focusing on improving air quality and conserving natural resources while addressing climate change.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | |
|---|---|---|---|
| Scope 1 | - | 000,000 | 000,000 |
| Scope 2 | 1,831,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 6,330,040 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Medidata is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
